A 25 percent reduction in the incidence of type 2 diabetes mellitus during the course of the trial.
Read More »Issue 122 Item 5 U.S. Life Expectancy Hits New High, But Not for Those with Diab
Death is on the decline for babies, adults and older people alike, with AIDS, homicide, cancer and heart disease all claiming fewer lives, but not for those with diabetes.
Read More »Issue 123 Item 4 Sildenafil Improves Endothelial Function in Type 2 Diabetics
In patients with type 2 diabetes, sildenafil (Viagra) improves flow-mediated dilatation (FMD), an index of nitric oxide-dependent endothelial function, according to a recent report.
Read More »Issue 124 Item 3 New Insulin Seen as Key to Saving Millions of Patients with Dia
Nanomized Insulin made of smaller particles and reduces number of daily injections.
Read More »Issue 125 Item 2 Repaglinide Versus Metformin in Combination With Bedtime NPH
Combined with bedtime NPH insulin, metformin provides superior glycemic control to repaglinide.
Read More »Issue 126 Item 1 1 in 4 Type 2 Diabetes Patients Have Heart Disease With No Symp
New screening tool can identify “silent coronary artery disease at an early stage in patients with diabetes
Read More »Issue 121 Item 5 As Cardiovascular Risk Increases So Does the Risk of Diabetes
Changes in serum triglycerides, HDL cholesterol, body mass index (BMI) and systolic blood pressure over time are associated with the risk of type 2 diabetes.
Read More »Three Giant Steps for Stem Cells
Specific genes have been identified that have the ability to develop into any of the 200.000 cells in the body.
Read More »Eli Lilly Cuts Deal for the Rights to a New Diabetes Drug from
Eli Lilly & Company will pay up to $325 million to Amylin Pharmaceuticals, a biotechnology company based in San Diego, for the rights to a potentially promising treatment for diabetes.
Read More »Issue 124 Item 2 High Cholesterol Can Predict Childhood Obesity
Although conventional wisdom is that obesity causes high cholesterol, results of a study in the September issue of the American Journal of Clinical Nutrition suggest that, at least for girls, high cholesterol can be a marker of obesity developing later in childhood.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.